AbbVie wins drug price control lawsuit against HHS
A federal judge in the U.S. District Court for the District of Columbia ruled Oct. 29 that AbbVie’s Botox must be excluded from Medicare’s Drug Price Negotiation Program, according to court documents.  On Feb. 11, AbbVie challenged HHS’ decision to include Botox in Medicare’s drug price negotiations, arguing the drug qualifies as a “plasma-derived product” […] The post AbbVie wins drug price control lawsuit against HHS appeared first on Becker's Hospital R...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.